Global taskforce set to demystify and overcome vaccine hesitancy amid COVID-19 pandemic

International experts are joining forces to combat vaccine hesitancy by tackling its root cause

23 Feb 2021
Diane Li
Assistant Editor

Industry news

International experts are joining forces to combat vaccine hesitancy by tackling its root cause – misinformation – and arming key influencers with the facts.

The pioneering project, led by the University of Bristol and involving teams in Canada, Germany, Finland, France, and Portugal, will harness the potential of health care professionals to challenge misconceptions about vaccination, reinforce confidence in vaccines, and encourage uptake of the COVID-19 vaccine, including being immunized themselves.

Professor Stephan Lewandowsky, Chair in Cognitive Science at the University of Bristol, who is heading the taskforce, said: “This is vital work, which will play a key role in fighting the deadly virus and other infectious diseases. Vaccine hesitancy is a significant issue across the world, including in the UK, and concerted efforts are needed to understand more about its origins and find effective ways to reduce fear and uncertainty, and build confidence in vaccines which are our best shot out of the pandemic.”

Vaccine hesitancy, defined as the delay or refusal of vaccination without medical guidance, has been recognized as a serious threat by the World Health Organization (WHO). Misinformation on the internet is a commonly cited cause and health care workers have been identified as trusted influencers, who can help sway vaccine decisions.

However, some evidence also indicates that not all health care workers are fully inclined to be vaccinated. For instance, latest figures from the Office for National Statistics (ONS) in the UK show although only 1 per cent of those offered vaccination against COVID-19 have turned it down, there is significant variation by age. Some 5 percent refused in the 30 to 49-year-olds age group, 2 percent among 50 to 69-year-olds and less than 1 percent in those aged 70 or above. It is possible many of the 30 to 49-year-olds are health and social care workers, since they are among the limited other groups already eligible to receive the vaccine, besides people aged 65 and above, due to being at greater risk. The percentage of refusals among health care workers is even higher in some of the other participating countries.

Professor Lewandowsky said: “It is important that health care workers are vaccinated and communicate the benefits of vaccinations, especially given their close contact with vulnerable patients and how their attitudes and actions may be followed by others. Ultimately we need them fully on board with the vaccination program to keep themselves and the wider community safe and protected.”

The £2.7 million research, funded by the European Union’s Horizon 2020 program, will systematically investigate attitudes towards vaccinations among health care workers in the participating countries. Arguments made by anti-vaccination activists will be analyzed and used to develop tools and techniques to challenge and refute such claims via health care workers. The project thus seeks to turn toxic misinformation into a potential asset based on the premise that the best way to acquire knowledge and to combat misperceptions is by employing misinformation itself, either in weakened doses as a cognitive “vaccine”, or through a thorough analysis of misinformation during what is called “refutational learning”. Learning to refute misinformation can be the best way to acquire valid scientific knowledge.

The guidance will be deployed by the WHO and the United Nations International Children’s Emergency Fund (UNICIF) for worldwide benefit.

Professor Adam Finn, Professor of Paediatrics at the University of Bristol and Chair of the World Health Organization European Technical Advisory Group on Immunisation, said: “Although great strides are being made with COVID-19 vaccination programs across the world, the spread of misinformation poses a significant threat to this progress. That’s why this is such an important research project, which could hold the key to improving vaccine uptake and reducing health inequalities. There is evidence to indicate greater vaccine hesitancy within BAME communities, which is particularly concerning since people from ethnic minorities have been shown to be at significantly greater risk of dying from COVID-19. Encouraging and reassuring health and social care workers to be vaccinated, and in turn enlisting their support to act as advocates to urge others, including patients, to follow will play a crucial part in reducing infection rates and saving lives.”

The research project will bolster other high-profile efforts to boost vaccine uptake, especially among target groups. Last night a celebrity-filled video urging people from ethnic minority communities to get the COVID-19 vaccine, which has also been shared online, was shown across the UK’s main commercial TV channels.

Professor Sander van der Linden, from the University of Cambridge, which is part of the task force, said: “The spread of misinformation about vaccination is one of the top global health threats. Our Social Decision-Making Lab is delighted to be part of this crucial and cutting-edge project to help develop a ‘psychological vaccine’ to inoculate health workers against influential misinformation.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Cellular PathologyCellular Pathology deals with the microscopic analysis of tissue samples and cells. Sample preparation and processing includes fixation, staining, sectioning and slide mounting, using equipment such microtomes and cryostats. In choosing immunohistochemistry and immunocytochemistry kits, consider chromogens, staining method, antibodies, microscopes and imaging.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.VirusesViruses are microscopic pathogens that require a host cell to replicate. Understanding their structure, replication cycle, and impact on the immune system is crucial in developing effective treatments, vaccines, and diagnostic methods. Research continues to focus on emerging viral diseases and antiviral drug discovery. Explore solutions for virus research, detection, and treatment in our peer-reviewed product directory; compare products, check customer reviews, and get pricing directly from manufacturers.Clinical StudyProspective biomedical or behavioral research studies on human subjects, following tests in animals, that are designed to answer specific questions about novel vaccines, drugs, treatments, dietary supplements, devices or new ways of using known interventions, generating safety and efficacy data.Vaccine DevelopmentVaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers. TherapeuticsTherapeutics are treatments designed to alleviate or cure diseases. These include pharmaceuticals, biologics, and gene therapies, which work by targeting specific disease mechanisms. Advances in personalized medicine and biologics offer new hope for patients with conditions that were previously difficult to treat. Browse our peer-reviewed product directory to find therapeutic solutions for various diseases; compare products, check user reviews, and get pricing directly from manufacturers.AntibodiesCoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.
Global taskforce set to demystify and overcome vaccine hesitancy amid COVID-19 pandemic